Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Quest Diagnostics (DGX) Stock Price & Analysis
838 Followers
DGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$117.60 - $145.62
Previous Close$137.09
Volume1.05M
Average Volume (3M)905.08K
Market Cap
$15.23B
Enterprise Value$20.02B
Total Cash (Recent Filing)$686.00M
Total Debt (Recent Filing)$5.37B
Price to Earnings (P/E)18.4
Beta0.55
Next Earnings
Jul 23, 2024EPS Estimate
$2.33Next Dividend Ex-Date
Jul 08, 2024Dividend Yield2.1%
Share Statistics
EPS (TTM)7.43
Shares Outstanding111,091,574
10 Day Avg. Volume693,274
30 Day Avg. Volume905,083
Standard Deviation0.09
R-Squared0.28
Alpha0.00103
Financial Highlights & Ratios
Price to Book (P/B)-5.96
Price to Sales (P/S)6.75
Price to Cash Flow (P/CF)7.30
P/FCF Ratio7.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.16
Enterprise Value/Gross Profit6.56
Enterprise Value/Ebitda17.17
Forecast
1Y Price Target
$146.09Price Target Upside6.92% Upside
Rating ConsensusHold
Number of Analyst Covering12
Quest Diagnostics News
Bulls Say, Bears Say
Bulls Say
AcquisitionsDGX's pipeline for additional outreach lab M&A remains promising, and the company anticipates it will be able to close additional transactions in 2024.
EarningsQ1:24 adjusted EPS of $2.04 beat estimates and consensus by +11% and +10%, respectively.
Revenue GrowthBase revenue grew 5.7%, with strong utilization across all channels and share gains.
Bears Say
Guidance2024 guidance was below expectations, with 1Q24 expected to be particularly weak.
MarginsMargins came out better than expected in the quarter but were still down y-o-y in the face of COVID pricing normalization, Haystack dilution, and wage inflation.
RegulationPotential FDA regulation of LDTs continues to weigh on stocks, with Final Rule possible later this month.
---
Ownership Overview
1.78% Insiders
32.36% Mutual Funds
27.66% Other Institutional Investors
38.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $117.60 and its highest was $145.62 in the past 12 months.
What is Quest Diagnostics’s market cap?
Currently, no data Available
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jul 23, 2024 which is in 20 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Apr 23, 2024. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.856 by $0.184.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 2.1%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is $2.33.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,091,576 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.04 in its last earnings report, beating expectations of $1.856. Following the earnings report the stock price went up 5.081%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 317M.
---
Quest Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$146.09 (6.92% Upside)
$146.09 (6.92% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 143.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.30%
12-Months-Change
Fundamentals
Return on Equity
13.49%
Trailing 12-Months
Asset Growth
9.07%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
---
DGX Earnings Call
Q1 2024
0:00 / 0:00
---
DGX Revenue Breakdown
97.02% Diagnostic Information Services
2.98% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$146.09
▲(6.92% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
24/37 ratings generated profit
1 Year Average Return
+5.89%
reiterated a buy rating 2 months ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 64.86% of your transactions generating a profit, with an average return of +5.89% per trade.
---